With the motivation to Eat, Inject, and Repeat that The Economist described in its cover story from 2nd March 2023, the story talks about the fast market growth of the GLP-1s as shown in the line chart here, with the forecasted market for these drugs reaching $150bn by 2031 about the market for todays cancer therapies
Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies
The GLP-1 plateau management guide discusses strategies that work across all incretin medications
The Importance of Addressing Weight Issues Substantial weight can significantly elevate the risk of developing chronic disorders such as type 2 diabetes, hypertension, heart disease, and more
Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles